COVID-19 and the management of interstitial lung disease patients – challenges and recommendations | European Respiratory Society

The ongoing COVID-19 epidemic affects interstitial lung diseases in all stages of disease and therapy. Preliminary data suggests a potential deleterious effect. Educational aims Pulmonologists and ILD specialists should be aware of the presentation and management of complications by COVID-19 in their patients. Format The webinar will be lecture-based, consisting of a 60 minute…

Read the full article here

Related Articles